(The Conversation is an independent and nonprofit source of news, analysis and commentary...
W. Garrett Nichols, MD, says he is motivated by “building a team of passionate people who are empowered to do their best work in the service of improving survival of patients with cancer.”
Plus, Jackie and Mike Bezos gave $710 million to Fred Hutch Cancer Center, and Massachusetts General Hospital got $50 million to expand sickle cell disease research and to support other programs.
March 4, 1940 – September 7, 2022
The Bezos Family Foundation announced a $710 million gift to the Seattle-based Fred Hutchinson Cancer Center
Seattle, Oct. 11, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global non-small cell lung cancer treatment market is estimated to...
In a boost to its Asia Pacific regional headquarters in Singapore, Merck has opened a new secondary packaging facility and broken ground on a separate facility that will manufacture next-generation inhalers. The two manufacturing sites are part of a $500 million investment to expand production of me…
Almost two years after securing its third drug approval, Alnylam is touting an expanded label for Oxlumo. The company put out word on Thursday night that the FDA approved an sNDA for its treatment lumasiran for primary hyperoxaluria type 1, also known as Ph1. The rare genetic disease, in which the
Only a few months after expanding its facility in Holly Springs, NC, vaccine maker CSL Seqirus is putting the new location to use with its latest contract. HHS’s BARDA has chosen CSL Seqirus to produce an H5N8 A/Astrakhan virus vaccine candidate for a Phase II study which is slated to
As abortion bans take effect nationwide, doctors and advocates have petitioned the FDA over concerns that the Supreme Court’s Dobbs decision leaves a drug used off-label for miscarriage treatment vulnerable to restrictions. The American College of Obstetricians and Gynecologists and 48 other organiz…
To date, only two gonorrhea vaccines have made it into human trials, with neither proving successful. Intravacc and Therapyx hope to make the third — and Intravacc, a Dutch CDMO, has now received a grant from NIAID for up to $14.6 million to push their vaccine candidate towards the clinic,
(Credit: Unsplash) This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Maggie Carter, Global Lead, AWS Global Soci…
Employees of Fred Hutchinson Cancer Center gathered to celebrate the rollout of the new brand at an event at the South Lake Union campus in late September.
Lifelong AIDS Alliance (Seattle) HistoryLink.org
SAN DIEGO--(BUSINESS WIRE)--Oct 4, 2022--
Mr. Richard Rosenblum, Dr. Colleen Delaney, and Mr. Charles Farrahar Appointed to the Board of Directors Bring a Combined 75 Years of Financial and Pharmaceutical Expertise SUWANEE, GA / ACCESSWIRE / September 29, 2022 / ViCapsys Life Sciences, Inc., (OTC PINK:VICP) (“ViCapsys” or the “Company”), to…
Topping off this weekend’s activities on the North Olympic Peninsula is the Great Port Townsend Bay Kinetic Skulpture Race on Saturday and Sunday.
Seagen Inc. (Nasdaq: SGEN), a world leader and pioneer in antibody-drug conjugate (ADC) therapies, and Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688), a p
<p>US FDA’s Vaccines and Related Biological Products Advisory Committee endorses Rebyota for recurrent C. difficile infection; most panelists prefer a product whose manufacturing will be regulated, even one with lingering concerns about efficacy or safety, over the current landscape.</p>
In an interview with Targeted Oncology, Mazyar Shadman, MD, MPH, discussed what community oncologists should keep in mind when treating patients who are viable for CAR T-cell therapy.